CN111484523B - Preparation method of optically pure trans-2- (diphenylphosphino) -1-cyclohexanecarboxylic acid - Google Patents
Preparation method of optically pure trans-2- (diphenylphosphino) -1-cyclohexanecarboxylic acid Download PDFInfo
- Publication number
- CN111484523B CN111484523B CN201910081416.3A CN201910081416A CN111484523B CN 111484523 B CN111484523 B CN 111484523B CN 201910081416 A CN201910081416 A CN 201910081416A CN 111484523 B CN111484523 B CN 111484523B
- Authority
- CN
- China
- Prior art keywords
- diphenylphosphine
- formula
- cyclohexanecarboxylic acid
- solvent
- trans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/5022—Aromatic phosphines (P-C aromatic linkage)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/505—Preparation; Separation; Purification; Stabilisation
- C07F9/5059—Preparation; Separation; Purification; Stabilisation by addition of phosphorus compounds to alkenes or alkynes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
技术领域technical field
本发明属于化学制备技术领域,具体涉及一种光学纯反式-2-(二苯基膦)-1-环己甲酸的制备方法。The invention belongs to the technical field of chemical preparation, in particular to a preparation method of optically pure trans-2-(diphenylphosphine)-1-cyclohexanecarboxylic acid.
背景技术Background technique
手性是自然界的普遍现象(常见于天然产物和药物)。不对称催化,是构建手性中心的最重要和直接的策略,一直是有机化学领域的研究热点之一。自2000年以来,一方面,手性小分子催化取得了瞩目的成绩;另一方面,不对称路易斯酸和过渡金属催化,依然占据重要地位,是极其有效的补充。而手性配体的设计和开发,是促进不对称路易斯酸和过渡金属催化发展的主要动力。Chirality is a common phenomenon in nature (common in natural products and pharmaceuticals). Asymmetric catalysis, the most important and direct strategy to construct chiral centers, has always been one of the research hotspots in the field of organic chemistry. Since 2000, on the one hand, chiral small molecule catalysis has made remarkable achievements; on the other hand, asymmetric Lewis acid and transition metal catalysis still occupy an important position and are extremely effective supplements. The design and development of chiral ligands is the main driving force for the development of asymmetric Lewis acids and transition metal catalysis.
在众多的配体中,膦配体是最为重要的一类配体之一,受到了各国科学家的关注和深入研究。2001年,Stelzer等报道了消旋反式-2-(二苯基膦)-1-环己甲酸的制备方法(Eur. J.Inorg.Chem.2001,1251-1259)。然而,光学活性纯反式-2-(二苯基膦)-1-环己甲酸的合成方法,一直未见报道。Among the many ligands, phosphine ligands are one of the most important types of ligands, and have attracted the attention and in-depth research of scientists from all over the world. In 2001, Stelzer et al. reported the preparation of racemic trans-2-(diphenylphosphine)-1-cyclohexanecarboxylic acid (Eur. J. Inorg. Chem. 2001, 1251-1259). However, the synthesis method of optically pure trans-2-(diphenylphosphino)-1-cyclohexanecarboxylic acid has not been reported.
发明内容SUMMARY OF THE INVENTION
发明目的:本发明目的在于针对现有技术的不足,提供一种光学纯反式2-(二苯基膦)-1-环己甲酸的制备方法,本发明另一目的在于提供该方法制备的光学纯反式2-(二苯基膦)-1-环己甲酸。Purpose of the invention: The purpose of the present invention is to provide a preparation method of optically pure trans 2-(diphenylphosphine)-1-cyclohexanecarboxylic acid in view of the deficiencies of the prior art, and another purpose of the present invention is to provide a method for preparing Optically pure trans 2-(diphenylphosphine)-1-cyclohexanecarboxylic acid.
技术方案:本发明所述的一种光学纯反式2-(二苯基膦)-1-环己甲酸的制备方法,由1-环己烯-1-甲酸甲酯与二苯基磷氧发生加成反应得到第一中间体,再由第一中间体经还原制得顺式-2-(二苯基膦)-1-环己甲酸甲酯,如式(I)或式(II)所示;向顺式-2-(二苯基膦)-1-环己甲酸甲酯中加入翻转剂和溶剂,加热回流后萃取、干燥,得到反式-2-(二苯基膦)-1-环己甲酸甲酯,如式(III)或式(IV)所示,经水解、酸化、再萃取,制得光学纯反式2-(二苯基膦)-1-环己甲酸,式(V)或式(VI)所示;Technical scheme: the preparation method of optically pure trans 2-(diphenylphosphine)-1-cyclohexanecarboxylic acid described in the present invention is composed of methyl 1-cyclohexene-1-carboxylate and diphenylphosphine An addition reaction occurs to obtain the first intermediate, and then the first intermediate is reduced to obtain cis-2-(diphenylphosphine)-1-cyclohexanecarboxylic acid methyl ester, such as formula (I) or formula (II) as shown; adding a turning agent and a solvent to cis-2-(diphenylphosphine)-1-cyclohexanecarboxylic acid methyl ester, heating under reflux, extraction and drying to obtain trans-2-(diphenylphosphine)- Methyl 1-cyclohexanecarboxylate, as shown in formula (III) or formula (IV), is subjected to hydrolysis, acidification and re-extraction to obtain optically pure trans-2-(diphenylphosphine)-1-cyclohexanecarboxylic acid, Formula (V) or formula (VI);
进一步地,所述的光学纯反式2-(二苯基膦)-1-环己甲酸的制备方法,包括如下步骤:Further, the preparation method of the optically pure trans 2-(diphenylphosphine)-1-cyclohexanecarboxylic acid comprises the following steps:
(1)向反应瓶中加入摩尔比为1~2:1的1-环己烯-1-甲酸甲酯与二苯基膦氧,并加入溶剂与催化剂,在-30~-15℃下反应40~50h,反应结束后加入淬灭剂,萃取后脱溶剂得到第一中间体,如式(VII)或式(VIII);(1) Add methyl 1-cyclohexene-1-carboxylate and diphenylphosphine oxygen with a molar ratio of 1~2:1 into the reaction flask, add a solvent and a catalyst, and react at -30~-15°
(2)向第一中间体中加入溶剂,并加入复合还原剂,在90~110℃下反应15~20h,加入淬灭剂,反应完成后经以正己烷/乙酸乙酯进行柱层析分离,得到得顺式-2-(二苯基膦)-1-环己甲酸甲酯,如式(I)或式(II)所示;(2) adding a solvent to the first intermediate, adding a composite reducing agent, reacting at 90-110 ° C for 15-20 h, adding a quenching agent, and separating by column chromatography with n-hexane/ethyl acetate after the reaction is completed , to obtain cis-2-(diphenylphosphine)-1-cyclohexanecarboxylic acid methyl ester, as shown in formula (I) or formula (II);
(3)向纯顺式-2-(二苯基膦)-1-环己甲酸甲酯体系中加入翻转剂甲醇钠和溶剂甲醇,加热回流20~30h,产物由乙酸酸化处理,经去溶剂、萃取、干燥、浓缩得到反式-2-(二苯基膦)-1-环己甲酸甲酯,如式(III)或式(IV)所示;(3) Add tumbler sodium methoxide and solvent methanol to the pure cis-2-(diphenylphosphine)-1-cyclohexanecarboxylic acid methyl ester system, heat under reflux for 20-30 h, the product is acidified with acetic acid, and the solvent is removed , extraction, drying and concentration to obtain trans-2-(diphenylphosphine)-1-cyclohexanecarboxylic acid methyl ester, as shown in formula (III) or formula (IV);
(4)将反式-2-(二苯基膦)-1-环己甲酸甲酯在氢氧化钾条件下进行水解,反应完成后,酸化、萃取、干燥,过滤减压脱除溶剂即得到光学纯反式2-(二苯基膦)-1-环己甲酸,式 (V)或式(VI)所示;(4) hydrolyzing methyl trans-2-(diphenylphosphine)-1-cyclohexanecarboxylate under potassium hydroxide condition, after completion of the reaction, acidify, extract, dry, filter and remove the solvent under reduced pressure to obtain Optically pure trans-2-(diphenylphosphine)-1-cyclohexanecarboxylic acid, represented by formula (V) or formula (VI);
具体反应过程如下方程式:The specific reaction process is as follows:
。 .
进一步地,为提高反应效率和产物纯度,步骤(1)中所述溶剂为四氢呋喃,催化剂为Bu2Mg/(R or S)-H8-BINOL与H2O,淬灭剂为饱和氯化铵;步骤(2)中所述复合还原剂为摩尔比为2:3的三氯硅烷和三乙胺混合物;所述溶剂为甲苯;Further, in order to improve the reaction efficiency and product purity, the solvent described in the step (1) is tetrahydrofuran, the catalyst is Bu 2 Mg/(R or S)-H 8 -BINOL and H 2 O, and the quencher is saturated chlorination Ammonium; the composite reducing agent described in the step (2) is a mixture of trichlorosilane and triethylamine whose molar ratio is 2:3; the solvent is toluene;
进一步地,步骤(3)中经减压除去溶剂后,向体系加入饱和碳酸氢钠处理,二氯甲烷萃取,无水硫酸钠干燥,过滤浓缩得到反式-2-(二苯基膦)-1-环己甲酸甲酯,如式(III)或式(IV)所示。Further, after removing the solvent under reduced pressure in step (3), adding saturated sodium bicarbonate to the system for treatment, extracting with dichloromethane, drying over anhydrous sodium sulfate, filtering and concentrating to obtain trans-2-(diphenylphosphine)- Methyl 1-cyclohexanecarboxylate, as shown in formula (III) or formula (IV).
进一步地,步骤(4)中反应完成后用盐酸酸化,二氯甲烷萃取,无水硫酸钠干燥,过滤减压脱除溶剂即得到光学纯反式2-(二苯基膦)-1-环己甲酸,式(V)或式(VI)所示。Further, in step (4), after the reaction is completed, acidify with hydrochloric acid, extract with dichloromethane, dry with anhydrous sodium sulfate, filter and remove the solvent under reduced pressure to obtain optically pure trans-2-(diphenylphosphine)-1-ring. Hexanoic acid, represented by formula (V) or formula (VI).
本发明还提供上述述制备方法制备的光学纯反式2-(二苯基膦)-1-环己甲酸,如式 (V)或式(VI)所示。The present invention also provides optically pure trans-2-(diphenylphosphine)-1-cyclohexanecarboxylic acid prepared by the above-mentioned preparation method, as shown in formula (V) or formula (VI).
有益效果:(1)本发明开创性的研究了光学纯反式2-(二苯基膦)-1-环己甲酸的制备方法,填补了膦配体中光学活性纯反式-2-(二苯基膦)-1-环己甲酸的空缺,有效促进了不对称路易斯酸和过渡金属催化效果;(2)本发明中,通过发明人对原料特性的研究,针对性的选择加成催化剂、还原催化剂、水解剂,配合相应的溶剂,不仅保证反应过程的顺利进行,还有助于提高产物的产率和纯度。Beneficial effects: (1) The present invention has pioneered research on the preparation method of optically pure trans-2-(diphenylphosphine)-1-cyclohexanecarboxylic acid, which fills in the optically active pure trans-2-( The vacancy of diphenylphosphine)-1-cyclohexanecarboxylic acid effectively promotes the catalytic effect of asymmetric Lewis acid and transition metal; (2) In the present invention, through the inventor's research on the properties of raw materials, the addition catalyst is selected pertinently , reduction catalyst, hydrolysis agent, and the corresponding solvent, not only ensure the smooth progress of the reaction process, but also help to improve the yield and purity of the product.
附图说明Description of drawings
图1为实施例1中产物的1H NMR谱图;Fig. 1 is the 1 H NMR spectrogram of the product in
图2为实施例1中产物的13C NMR谱图;Figure 2 is the 13 C NMR spectrum of the product in Example 1;
图3为实施例1中产物的31P NMR谱图;Figure 3 is the 31 P NMR spectrum of the product in Example 1;
图4为实施例2中产物的1H NMR谱图;Figure 4 is the 1 H NMR spectrum of the product in Example 2;
图5为实施例2中产物的13C NMR谱图;Figure 5 is the 13 C NMR spectrum of the product in Example 2;
图6为实施例2中产物的31P NMR谱图。FIG. 6 is a 31 P NMR spectrum of the product in Example 2. FIG.
具体实施方式Detailed ways
下面通过附图对本发明技术方案进行详细说明,但是本发明的保护范围不局限于所述实施例。实施例中所使用反应类药品均为常规市售。The technical solutions of the present invention will be described in detail below with reference to the accompanying drawings, but the protection scope of the present invention is not limited to the embodiments. The reaction drugs used in the examples are all commercially available.
实施例1:反式-2-(二苯基膦)-1-环己甲酸甲酯的制备Example 1: Preparation of methyl trans-2-(diphenylphosphine)-1-cyclohexanecarboxylate
在室温及N2保护下,将1.76g(R)-H8-BINOL,72μL H2O加入到40mL无水四氢呋喃中,在室温下剧烈搅拌5min,将溶于庚烷的4mmol二丁基镁逐滴加入到反应体系里,再将8.1g二苯基膦氧加入到反应体系中,在室温下剧烈搅拌5min,搅拌结束将反应体系降温至-20℃,在此温度下保持5min,环己烯甲酸甲酯(5.88g,42mmol)逐滴加入到反应体系中,滴加完毕在-20℃反应48h;反应结束后,用饱和氯化铵溶液淬灭反应,减压脱去溶剂,水相用氯仿萃取三次,萃取得到的有机相用无水硫酸钠干燥,减压脱除溶剂,残余物用乙醚重结晶,得到8.65g顺式-2-(二苯基膦)-1-环己甲酸甲酯,产率62.5%,ee值100%,dr值100%;At room temperature and under the protection of N 2 , 1.76 g (R)-H 8 -BINOL, 72 μL H 2 O were added to 40 mL of anhydrous tetrahydrofuran, vigorously stirred at room temperature for 5 min, and 4 mmol of dibutylmagnesium dissolved in heptane was added. Add dropwise to the reaction system, then add 8.1 g of diphenylphosphine oxygen to the reaction system, stir vigorously for 5 min at room temperature, and after stirring, cool down the reaction system to -20 ° C, keep at this temperature for 5 min, cyclohexane Methyl enolate (5.88 g, 42 mmol) was added dropwise to the reaction system, and the dropwise addition was completed at -20 °C for 48 h; after the reaction was completed, the reaction was quenched with saturated ammonium chloride solution, the solvent was removed under reduced pressure, and the aqueous phase Extracted with chloroform three times, the organic phase obtained by extraction was dried over anhydrous sodium sulfate, the solvent was removed under reduced pressure, and the residue was recrystallized with ether to obtain 8.65 g of cis-2-(diphenylphosphine)-1-cyclohexanecarboxylic acid Methyl ester, yield 62.5%, ee
在室温及N2保护下,将2.1g,6.4mmol顺式-2-(二苯基膦)-1-环己甲酸甲酯和1.74g, 32.2mmol甲醇钠加入到反应瓶中,然后加入45mL无水甲醇,加热回流24h,随后将混合物冷却至室温,用乙酸酸化至浑浊液体变澄清,减压脱除溶剂,加入30mL饱和碳酸氢钠溶液并用30mL×3二氯甲烷萃取。将合并的有机相用无水硫酸钠干燥,过滤并减压脱除溶剂,进行柱层析,洗脱液:正己烷:乙酸乙酯=50:1~20:1,纯化粗产物,得到2.1g反式-2-(二苯基膦)-1-环己甲酸甲酯,产率100%,ee值100%,通过手性HPLC 分析测定对映体纯度。Under the protection of N at room temperature, 2.1g, 6.4mmol of cis- 2- (diphenylphosphine)-1-cyclohexanecarboxylic acid methyl ester and 1.74g, 32.2mmol of sodium methoxide were added to the reaction flask, and then 45mL was added Anhydrous methanol, heated to reflux for 24 h, then the mixture was cooled to room temperature, acidified with acetic acid until the cloudy liquid became clear, the solvent was removed under reduced pressure, 30 mL of saturated sodium bicarbonate solution was added and extracted with 30 mL×3 dichloromethane. The combined organic phases were dried over anhydrous sodium sulfate, filtered and the solvent was removed under reduced pressure, and subjected to column chromatography, eluent: n-hexane:ethyl acetate=50:1~20:1, and the crude product was purified to obtain 2.1 g methyl trans-2-(diphenylphosphino)-1-cyclohexanecarboxylate, 100% yield, 100% ee, enantiomeric purity determined by chiral HPLC analysis.
实施例1所得产物的结构表征数据如下所示:The structural characterization data of the product obtained in Example 1 are as follows:
1H NMR(400MHz,CDCl3):δ7.80-7.44(m,4H),7.39-7.18(m,6H),3.50(s,3H),2.67-2.61(m,1H),2.37-2.30(m,1H),2.01-1.91(m,1H),1.82-1.58(m,4H),1.41-1.28(m,1H),1.27-1.15(m,1H),1.03-0.87(m,1H). 1 H NMR (400 MHz, CDCl 3 ): δ 7.80-7.44 (m, 4H), 7.39-7.18 (m, 6H), 3.50 (s, 3H), 2.67-2.61 (m, 1H), 2.37-2.30 ( m,1H), 2.01-1.91(m,1H), 1.82-1.58(m,4H), 1.41-1.28(m,1H), 1.27-1.15(m,1H), 1.03-0.87(m,1H).
13C NMR(100MHz,CDCl3):δ175.74,136.14,136.02,135.32,134.86,134.66,132.82, 132.65,129.14,128.35,128.29,128.24,128.21,128.17,51.45,46.32,46.13,35.62,35.48, 30.07,29.96,27.06,25.51,24.81. 13 C NMR(100MHz,CDCl 3 ):δ175.74,136.14,136.02,135.32,134.86,134.66,132.82, 132.65,129.14,128.35,128.29,128.24,128.21,128.17,51.45,46.32,46.13,35.62,35.48, 30.07, 29.96, 27.06, 25.51, 24.81.
31P NMR(161MHz,CDCl3):δ-3.04. 31 P NMR (161 MHz, CDCl 3 ): δ-3.04.
通过产物的核磁共振氢谱、碳谱、磷谱,证明成功合成反式-2-(二苯基膦)-1-环己甲酸甲酯。The successful synthesis of trans-2-(diphenylphosphine)-1-cyclohexanecarboxylic acid methyl ester was proved by the H NMR, C and P spectra of the product.
式(III)化合物的比旋光度:[α]D 20=36.9(c=0.10,MeOH).The specific optical rotation of the compound of formula (III): [α] D 20 =36.9 (c=0.10, MeOH).
HRMS:calculated for C20H23O2P(M+H)+:327.1514found:327.1508.HRMS:calculated for C 20 H 23 O 2 P(M+H) + :327.1514found:327.1508.
式(IV)化合物的比旋光度:[α]D 20=-36.9(c=0.10,MeOH).The specific optical rotation of the compound of formula (IV): [α] D 20 =-36.9 (c=0.10, MeOH).
HRMS:calculated for C20H23O2P(M+H)+:327.1514,found:327.1508.HRMS: calculated for C 20 H 23 O 2 P(M+H) + : 327.1514, found: 327.1508.
实施例2:反式-2-(二苯基膦)-1-环己甲酸的制备Example 2: Preparation of trans-2-(diphenylphosphine)-1-cyclohexanecarboxylic acid
在室温及N2保护下,将0.9g,2.76mmol反式-2-(二苯基膦)-1-环己甲酸甲酯溶于50 mL N2脱气处理的11mL乙醇中,然后加入10mL,4.96mmol,0.5M,N2脱气处理的氢氧化钾水溶液。将混合物在回流条件下过夜反应。随后将混合物冷却至室温,减压除去溶剂,加入20mL H2O,用2M盐酸酸化该溶液至pH=1,二氯甲烷萃取,有机相合并用无水硫酸钠干燥,除去溶剂得到0.7g反式-2-(二苯基膦)-1-环己甲酸,产率81%。0.9 g, 2.76 mmol of methyl trans-2-(diphenylphosphine)-1-cyclohexanecarboxylate were dissolved in 50 mL of N degassed 11 mL of ethanol at room temperature under N2 protection, and then 10 mL of , 4.96 mmol, 0.5 M, N2 degassed aqueous potassium hydroxide solution. The mixture was reacted overnight under reflux conditions. The mixture was then cooled to room temperature, the solvent was removed under reduced pressure, 20 mL of H2O was added, the solution was acidified to pH=1 with 2M hydrochloric acid, extracted with dichloromethane, the organic phases were combined and dried over anhydrous sodium sulfate, and the solvent was removed to give 0.7 g of Formula-2-(diphenylphosphine)-1-cyclohexanecarboxylic acid, 81% yield.
实施实例2所得产物的结构表征数据如下所示:The structural characterization data of implementation example 2 products therefrom are as follows:
1H NMR(400MHz,CHCl3):δ7.56-7.44(m,4H),7.39-7.23(m,6H),2.73-2.68(m,1H),2.40-2.28(m,1H),2.10-1.98(m,1H),1.91-1.59(m,4H),1.44-1.21(m,2H),1.06-0.95(m,1H). 1 H NMR (400 MHz, CHCl 3 ): δ 7.56-7.44 (m, 4H), 7.39-7.23 (m, 6H), 2.73-2.68 (m, 1H), 2.40-2.28 (m, 1H), 2.10- 1.98(m,1H),1.91-1.59(m,4H),1.44-1.21(m,2H),1.06-0.95(m,1H).
13C NMR(100MHz,CDCl3):δ181.64,136.26,136.14,135.41,135.27,134.92,134.71, 132.95,132.77,129.28,128.53,128.46,128.40,128.32,45.47,45.28,35.04,34.91,29.36, 29.26,26.57,26.52,25.01,24.97,24.64. 13 C NMR(100MHz,CDCl 3 ):δ181.64,136.26,136.14,135.41,135.27,134.92,134.71, 132.95,132.77,129.28,128.53,128.46,128.40,128.32,45.47,45.28,35.04,34.91,29.36, 29.26, 26.57, 26.52, 25.01, 24.97, 24.64.
31P NMR(161MHz,CDCl3):δ-4.04. 31 P NMR (161 MHz, CDCl 3 ): δ-4.04.
通过产物的核磁共振氢谱、碳谱、磷谱,证明成功合成反式-2-(二苯基膦)-1-环己甲酸。The successful synthesis of trans-2-(diphenylphosphine)-1-cyclohexanecarboxylic acid was proved by the H NMR, C and P spectra of the product.
式(V)化合物的比旋光度:[α]D 20=34.3(c=0.10,MeOH).The specific optical rotation of the compound of formula (V): [α] D 20 =34.3 (c=0.10, MeOH).
HRMS:calculated for C19H21O2P(M+H)+:313.1357,found:313.1356.HRMS:calculated for C 19 H 21 O 2 P(M+H) + :313.1357,found:313.1356.
式(VI)化合物的比旋光度:[α]D 20=-34.3(c=0.10,MeOH).The specific optical rotation of the compound of formula (VI): [α] D 20 =-34.3 (c=0.10, MeOH).
HRMS:calculated for C19H21O2P(M+H)+:313.1357,found:313.1356.HRMS:calculated for C 19 H 21 O 2 P(M+H) + :313.1357,found:313.1356.
本发明开创性的研究了光学纯反式2-(二苯基膦)-1-环己甲酸的制备方法,填补了膦配体中光学活性纯反式-2-(二苯基膦)-1-环己甲酸的空缺,有效促进了不对称路易斯酸和过渡金属催化效果。The invention groundbreakingly studies the preparation method of optically pure trans-2-(diphenylphosphine)-1-cyclohexanecarboxylic acid, and fills in the optically active pure trans-2-(diphenylphosphine)- The vacancy of 1-cyclohexanecarboxylic acid effectively promotes the catalytic effect of asymmetric Lewis acid and transition metal.
如上所述,尽管参照特定的优选实施例已经表示和表述了本发明,但其不得解释为对本发明自身的限制。在不脱离所附权利要求定义的本发明的精神和范围前提下,可对其在形式上和细节上作出各种变化。As mentioned above, although the present invention has been shown and described with reference to specific preferred embodiments, this should not be construed as limiting the invention itself. Various changes in form and details may be made therein without departing from the spirit and scope of the present invention as defined by the appended claims.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910081416.3A CN111484523B (en) | 2019-01-28 | 2019-01-28 | Preparation method of optically pure trans-2- (diphenylphosphino) -1-cyclohexanecarboxylic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910081416.3A CN111484523B (en) | 2019-01-28 | 2019-01-28 | Preparation method of optically pure trans-2- (diphenylphosphino) -1-cyclohexanecarboxylic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111484523A CN111484523A (en) | 2020-08-04 |
CN111484523B true CN111484523B (en) | 2022-07-08 |
Family
ID=71812148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910081416.3A Active CN111484523B (en) | 2019-01-28 | 2019-01-28 | Preparation method of optically pure trans-2- (diphenylphosphino) -1-cyclohexanecarboxylic acid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111484523B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02188591A (en) * | 1989-01-13 | 1990-07-24 | Nippon Fine Chem Co Ltd | 2-(diphenylphosphino)-cycloalkane derivative, production thereof and catalyst for asymmetric synthesis |
-
2019
- 2019-01-28 CN CN201910081416.3A patent/CN111484523B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02188591A (en) * | 1989-01-13 | 1990-07-24 | Nippon Fine Chem Co Ltd | 2-(diphenylphosphino)-cycloalkane derivative, production thereof and catalyst for asymmetric synthesis |
Non-Patent Citations (3)
Title |
---|
David J. Brauer等.Novel Electron-Rich Hydrophilic Phosphanes with Carboxylated Cyclohexyl Substituents.《Eur. J. Inorg. Chem.》.2001, * |
Manabu Hatano等.Chiral Magnesium(II) Binaphtholates as Cooperative Bronsted/Lewis Acid–Base Catalysts for the Highly Enantioselective Addition of Phosphorus Nucleophiles to α,β-Unsaturated Esters and Ketones.《Angew. Chem. Int. Ed.》.2013,第52卷 * |
Manabu Node等.Hard Acid and Soft Nucleophile Systems.3. Dealkylation of Esters with Aluminum Halide-Thiol and Aluminum Halide-Sulfide Systems.《J. Org. Chem.》.1981,第46卷 * |
Also Published As
Publication number | Publication date |
---|---|
CN111484523A (en) | 2020-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113999142B (en) | Preparation method of chiral N-Boc-trans-1, 2-cyclohexanediamine | |
CN105833911B (en) | The Cr Anderson types heteropolyacid catalyst of 1 Phenethylthiourea modification, preparation method and applications | |
CN111454230B (en) | Synthesis method of key intermediate Tuv of natural anticancer drug Tubulysins | |
CN101735085B (en) | Method for preparing D-serine by kinetic resolution | |
CN103044468B (en) | Preparation method of N-(2-pyrazine carbonyl)-L-phenylalanine-L- leucine boracic acid | |
CN110922315A (en) | Preparation method of Laolatinib intermediate compound | |
CN109942459B (en) | Method for synthesizing 3-difluoromethyl-3-acrylonitrile compounds | |
CN103242375B (en) | A kind of High-activity bifunctional catalyst and application thereof preparing chiral epoxy alkane and glycol | |
CN111484523B (en) | Preparation method of optically pure trans-2- (diphenylphosphino) -1-cyclohexanecarboxylic acid | |
CN101412672B (en) | Chemical synthesis method for R-2-hydroxy-4-phenylbutanoate | |
CN110483317B (en) | Preparation method and application of 3-isobutyl dimethyl glutarate | |
CN115260126B (en) | Chiral quaternary ammonium salt with (S) -binaphthyl, preparation method and application | |
CN112645813B (en) | Preparation method of (R) -3-cyclohexene carboxylic acid | |
CN111484522B (en) | A kind of preparation method of optically pure cis 2-(diphenylphosphine)-1-cyclohexanecarboxylic acid | |
CN104402690B (en) | The preparation method of method Buddhist nun's aldehyde and accompany the preparation method of auspicious tretinoin | |
CN115490591A (en) | Oseltamivir phosphate intermediate impurity compound and preparation method and application thereof | |
CN101743218B (en) | Preparation method and intermediate of optically active trans-2-aminocyclohexanol | |
CN108948055B (en) | 8-methylquinoline gem-diboron compound and preparation method thereof | |
CN108424383B (en) | Preparation method of curcumin nicotinate | |
CN110128303B (en) | A kind of method of synthesizing musk extract (2R, 5R)-Muscide-A1 | |
CN114573489B (en) | Separation method of carboprost | |
CN120208783A (en) | Preparation method of long-chain alkyl diacid mono-tert-butyl ester | |
CN109081785B (en) | Synthetic method of fluorine-containing glycine ester derivative | |
CN109665967B (en) | Ligand for asymmetric epoxidation reaction of indene compounds and preparation method and application thereof | |
CN114573457A (en) | Preparation method of malonic half ester |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |